Literature DB >> 12014619

Innovative prevention strategies for radiation necrosis of the central nervous system.

Carsten Nieder1, Nicolaus Andratschke, Roger E Price, Belinda Rivera, K Kian Ang.   

Abstract

The authors have reviewed the experimental data on the radio-response of the central nervous system (CNS) and summarize the development of rational prevention strategies for radiation necrosis. Currently, radiation necrosis is thought to result from complex dynamic interactions between parenchymal and vascular endothelial cells within the CNS. The latent time, preceding the clinical manifestation of damage, is viewed as an active phase where cytokines and growth factors play important roles in inter- and intracellular communication. The present pathogenetic model forms the basis of rational innovative prevention strategies, which are now being studied in vivo. They include treatment with growth factors as well as neural stem cell transplantation and neoangiogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 12014619

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Peritumoral and intratumoral hemorrhage after stereotactic radiosurgery for renal cell carcinoma metastasis to the brain.

Authors:  Fotios Kalfas; Nello Ronchini; Tomasz Tadeusz Godowicz; Paolo Cavazzani; Paolo Severi
Journal:  J Radiosurg SBRT       Date:  2011

Review 2.  Pharmacological interventions to treat or prevent neurocognitive decline after brain radiation.

Authors:  Jessica W Rooney; Nadia N Laack
Journal:  CNS Oncol       Date:  2013-11

Review 3.  Pathological changes in the central nervous system following exposure to ionizing radiation.

Authors:  S Bálentová; M Adamkov
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

Review 4.  Molecular, Cellular and Functional Effects of Radiation-Induced Brain Injury: A Review.

Authors:  Sona Balentova; Marian Adamkov
Journal:  Int J Mol Sci       Date:  2015-11-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.